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The equine influenza disease is a highly contagious respiratory
pathology which affects horses, donkeys and mules, among other
equines. This disease is caused by two viral subtypes of influenza A
virus, H7N7 and H3N8, which belong to the Orthomyxoviridae family.
Nowadays influenza vaccines are
produced using eggs. The vaccine
contains inactivated virus. The
main drawbacks of this process are:
The vaccine contains the HA1
subunit of the influenza virus,
which is the subunit of the
influenza virus hemagglutinin
(HA).
The HA on the influenza virus is a trimer, it
is made of three copies of the HA
polypeptide.
15µg of HA1 (H7N7)
15µg of HA1 (H3N8)
Adjuvant
The HA is the viral protein that attaches to 
cell receptors, causing fusion of both, viral 
and cellular membranes.
The veterinary equine market is one of the least exploited and
so it is a great business opportunity to work on it now and in
a near future due to the increase in the next years.
Legally all competing horses must be vaccinated twice a year.
The USA is the country with the highest number of horses,
9.5M, and among these 3.5M are federated competition
horses.
3.5M of horses that
are federated and
in competition.
A total of 8M doses would be
produced and distributed
around the world.
The production of the vaccine using the
baculovirus expression system has several
advantages
Insect cells are used instead of
mammals, due to de fact that are
easier to maintain.
With the addition of some
protective agents, high
five cells can have high
productivity, being the
optimum choice for the
recombinant protein
production.
Alternative cell cultures
• They have a restricted host range, limited to 
invertebrate species
• Easy to manipulate 
• High levels of heterologous gene expression, due to 
their strong promoters
Sf9 HighFive
✓Resilient Sensible
Lower protein 
productivity
✓High protein 
productivity
✓Good in 
virus 
amplification
Bad in virus 
amplification
Reduces vaccine production time
Growth of all influenza viruses
No need for chicken eggs
Animal component free
High purified and safe vaccine
8M Doses 
5 M 
USA
1,5 M 
Europe
1 M 
UAE
0,5 M 
South 
America
The plant will be
located in the United
States of America.
• Avoid import taxes
• High number of federate horses in 
competition
USA
• Laboratory    Viral generation
• Production processPLANT
• Biosafety level 3 
• Under the umbrella of QbDGMP
Long production time
Large infrastructure
Allergies
Dependence to eggs
The process is divided in 3 parts :
 Upstream
- Virus stock generation
- Cellular scaling up
Reaction
- Protein production
Downstream
- Separation
- Concentration
- Purification
- Packaging the final product
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Part I: Design basics
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THE INFLUENZA VACCINE
BACULOVIRUS EXPRESSION SYSTEM
MARKET
PLANT LOCALITATION AND 
ORGANIZATION
THE FIRST EQUINE VACCINE
PRODUCED USING CELLS
THE FINAL PRODUCT
WILL CONTAIN 30µg
OF HA1 AND 1.5mL OF
ADJUVANT.
12 batches/year
First peak
3 batches 
for H7N7
3 batches 
for H3N8
Second 
peak
3 batches 
for H7N7
3 batches 
for H3N8
1 month of process
Virus Stock 
Generation
Cellular 
scaling up
Bioreactor 
1000L Centrifugation
Viral 
Inactivation
Freeze
Dryer
Anionic Exchage
Chromatography
Vacuum 
Evaporation
Ultrafiltration
Diafiltration
2x
Blending 
Tank
Blending 
Tank
Design of an industrial bioprocess plant with the simulator SuperPro Designer for
the production of the equine influenza vaccine using a baculovirus expression
system in insect cell lines, and subsequent analysis of its sustainability.
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